Common Stock, Par or Stated Value Per Share in USD/shares of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD/shares
Description: Face amount or stated value per share of common stock.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Par or Stated Value Per Share history and change rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Common Stock, Par or Stated Value Per Share for the quarter ending 30 Jun 2023 was 0 USD/shares, unchanged year-over-year.

Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)

Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Common Stock, Par or Stated Value Per Share (USD/shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$0	$0	0%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$0			31 Mar 2023	10-Q	11 May 2023
Q4 2022	$0	$0	0%	31 Dec 2022	10-Q	09 Aug 2023
Q2 2022	$0			30 Jun 2022	6-K	29 Aug 2022
Q4 2021	$0	$0	0%	31 Dec 2021	10-K	30 Mar 2023
Q4 2020	$0			31 Dec 2020	20-F	26 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.